Put down that beer; it's not a tanning lotion
UC cosmetic science expert joins WVXU's Cincinnati Edition
The University of Cincinnati's Kelly Dobos joined WVXU's Cincinnati Edition to discuss what's fact and what's myth when it comes to sunscreen use, different kinds of sunscreen and a social media recommendation to use beer on your skin to help get a tan.
"There’s no scientific evidence that putting beer on your skin will help you develop a tan," said Dobos, a cosmetic chemist and adjunct instructor in UC's Cosmetic Science Program in the James L. Winkle College of Pharmacy. "The only thing I think it’s scientifically proven to do is to make your skin sticky and attract bugs."
Dobos noted even if this myth were true, purposefully aiming to get a tan should not be a goal.
"If you’re not using sunscreen to protect your skin and you’re trying to get a tan, what I would say is that tanning is your skin trying to protect itself," she said. "So you've already done damage when you’re developing a tan. Your skin is producing more melanin trying to protect the DNA in your cells from future sun damage. So it’s really important if you’re going to be out in the sun for a prolonged period of time to wear sunscreen."
Listen to the Cincinnati Edition segment.
Dobos was also recently featured in an Elle Magazine/Yahoo News article discussing why the United States has fewer sunscreen options compared to European countries. Read the story on Yahoo News or Elle.
Featured photo a top of a person applying sunscreen. Photo/simonkr/iStock.
Related Stories
Local 12: Pharmacies adjusting hours due to staffing issues
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
WVXU: Exploring the under-regulated dietary supplements industry
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
Drug Discovery News: Silence in healthy cells makes FOXR2 a potential cancer target
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.